Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Allogene Therapeutics (ALLO) Intangibles (2019)

Allogene Therapeutics (ALLO) has disclosed Intangibles for 1 consecutive years, with $151000.0 as the latest value for Q4 2019.

  • Quarterly Intangibles changed N/A to $151000.0 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $151000.0 through Dec 2019, changed N/A year-over-year, with the annual reading at $151000.0 for FY2019, N/A changed from the prior year.
  • Intangibles hit $151000.0 in Q4 2019 for Allogene Therapeutics, down from $301000.0 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $603000.0 in Q1 2019 to a low of $151000.0 in Q4 2019.